MiniMed Group Inc (MMED)
MiniMed Group, Inc. is a healthcare technology company focused on diabetes management. The company develops, manufactures, and markets medical equipment and related digital tools used by people who require insulin therapy, including those with type 1 diabetes and a portion of those with type 2 diabetes. Its product portfolio includes insulin delivery devices such as pumps and pens, continuous glucose monitors, consumables and supplies, and associated software and services. MiniMed Group also develops automated insulin delivery systems designed to support glucose sensing and insulin administration, as well as smart multiple daily injection systems for manual insulin use, including products such as InPen, Simplera, and Guardian 4. Founded in 1983, the company is headquartered in Northridge, California. As of March 25, 2026, it operates independently of Medtronic Global Holdings S.C.A.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MMED
|
$17.98
|
2.9% Upside
|
Fair
|
$20.60
|
17.9% Upside
|
Fair
|
Good
|
—
|
—
|
—
|
0.0%
|
September 30, 2026
|
-14.7x
|
1.4x
|
1.6x
|
4.752 B
|
4.561 B
|
1.1%
|
10.0%
|
4.6
|
-68.8%
|
126.1%
|
